Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours by William CW Wong et al.
BioMed CentralEmerging Themes in Epidemiology
ssOpen AcceAnalytic perspective
Development of a quality assessment tool for systematic reviews of 
observational studies (QATSO) of HIV prevalence in men having 
sex with men and associated risk behaviours
William CW Wong*1, Catherine SK Cheung2 and Graham J Hart3
Address: 1Department of General Practice, 200 Berkeley Street, Carlton, Vic 3053, Australia, 2Department of Community and Family Medicine, the 
Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, PR China and 3Centre for Sexual Health and HIV Research, University 
College London, Mortimer Market Centre (off Capper St), London, WC1E 6JB, UK
Email: William CW Wong* - w.wong@unimelb.edu.au; Catherine SK Cheung - catherine_cheung@cuhk.edu.hk; 
Graham J Hart - GHart@gum.ucl.ac.uk
* Corresponding author    
Abstract
Background: Systematic reviews based on the critical appraisal of observational and analytic
studies on HIV prevalence and risk factors for HIV transmission among men having sex with men
are very useful for health care decisions and planning. Such appraisal is particularly difficult,
however, as the quality assessment tools available for use with observational and analytic studies
are poorly established.
Methods: We reviewed the existing quality assessment tools for systematic reviews of
observational studies and developed a concise quality assessment checklist to help standardise
decisions regarding the quality of studies, with careful consideration of issues such as external and
internal validity.
Results: A pilot version of the checklist was developed based on epidemiological principles,
reviews of study designs, and existing checklists for the assessment of observational studies. The
Quality Assessment Tool for Systematic Reviews of Observational Studies (QATSO) Score
consists of five items: External validity (1 item), reporting (2 items), bias (1 item) and confounding
factors (1 item). Expert opinions were sought and it was tested on manuscripts that fulfil the
inclusion criteria of a systematic review. Like all assessment scales, QATSO may oversimplify and
generalise information yet it is inclusive, simple and practical to use, and allows comparability
between papers.
Conclusion: A specific tool that allows researchers to appraise and guide study quality of
observational studies is developed and can be modified for similar studies in the future.
Introduction
Epidemiological evidence-based research is becoming an
increasingly important basis for health care decisions and
planning. There is a dearth of reviews of observational and
analytic studies on HIV prevalence and risk factors for HIV
transmission among men having sex with men (MSM),
and this is particularly the case in mainland China [1-3].
We sought to conduct a rigorous systematic review sum-
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their associated high risk behaviours in China, with the
aim of providing systematic and comprehensive data for
policymakers to devise appropriate plans for health pro-
motion and interventions to control the spread of HIV in
the target population.
A number of consensus statements have previously been
prepared to encourage higher quality of reporting, includ-
ing recommendations for reporting systematic reviews
(QUOROM)[4], randomized trials (CONSORT)[5], stud-
ies of diagnostic tests (STARD)[6], meta-analyses of obser-
vational studies (MOOSE)[7] and observational
epidemiological studies (STROBE)[8,9]. However all
these were aimed at authors of reports, not at those seek-
ing to assess the validity of what they read [10]. Of partic-
ular relevance here are the MOOSE and STROBE
statements, both of which were developed as checklists
designed to assist authors when writing up analytical
observational studies, to support editors and reviewers
when considering such articles for publication, and to
help readers when critically appraising published articles
[8]. However, there remains a clear disparity between the
quality of tools available to aid the critical appraisal of
observational studies when compared with those availa-
ble for controlled trials, making the systematic review of
the former particularly difficult. We believe a quality
assessment tool is the key to any systematic review as it
allows original research to be objectively appraised and
evaluated, in order to inform subsequent decisions
regarding inclusion by evaluating, ranking, or scoring the
relevant studies [11-13].
A study conducted by Mallen and his coworkers [14] in
2006 revealed that quality assessment tools were grossly
under-utilised in the evaluation of observational studies,
in that only 13 out of 40 articles in 2003–2004 using pub-
lished checklists/quality assessment tools such as NHS
CRD [15,16], MOOSE [7], Downs and Black checklist [17]
and Ottawa-Newcastle tool [18]. Of such tools, the New-
castle-Ottawa Scale (NOS) is one of the more comprehen-
sive instruments for assessing the quality of non-
randomised studies in meta-analyses: the 8-item instru-
ment consists of three subscales, namely, selection of sub-
jects (4-item), comparability of subjects (1-item),
assessment of outcome/exposure (3-item). Despite hav-
ing been recommended by the Cochrane Non-Rand-
omized Studies Methods Working Group [19], it is only
partly validated and primarily used to appraise cohort
studies and case-control studies [18]. In short, our major
challenge is that each study is to some extent unique, and
that a quality checklist may consequently not include
items that may be considered relevant for the purposes of
the intended meta-analysis. We therefore set out to
develop a concise quality assessment checklist to help
standardise decisions regarding the quality of studies,




Often both internal and external validity are assessed
together during methodological quality assessment as
interpretation of the findings of a study depends on
design, conduct and analyses (internal validity), as well as
on populations, interventions and outcome measures
(external validity). The information gained from quality
assessment is crucial in determining the strength of infer-
ences and in assigning grades to recommendations gener-
ated within a review.
Our team proposed to identify case-control studies, cross-
sectional studies with case-control design in the ques-
tions, and those intervention studies that address preva-
lence rates. A pilot version of the checklist was developed
based on epidemiological principles, reviews of study
designs, and existing checklists for the assessment of
observational studies. It was later modified in light of pre-
liminary and pilot application. The final tool, abbreviated
as QATSO Score, covers the following aspects (Additional
file 1):
1) External validity (1 item) – addresses the extent to
which the findings from the study can be generalised to
the population from which the study subjects are derived.
2) Reporting (2 items) – assesses whether the information
provided in the paper is sufficient to allow a reader to
make an unbiased assessment of the findings of the study.
One of the items is specific for prevalence studies.
3) Bias (1 item) – addresses bias in the measurement of
the outcomes in a study.
4) Confounding (1 item) – addresses whether studies
have applied adjustment for confounding in the analysis.
This item is specific to studies concerning association of
risk factors.
Although the QATSO Score consists of five items, users
may select 4–5 items depending on the type of studies
being evaluated. Studies achieving 67% or more in the
score will be regarded as "good" quality; 34–66% "fair";
and, below 33% "poor".
Testing
Experts from the Hong Kong Branch of the Chinese
Cochrane Centre and local HIV researchers (see acknowl-
edgement) were invited to provide comments on the con-
tent validity of the assessment tool. This assessment toolPage 2 of 4
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test the consistency of study quality. The two reviewers
were asked to assess 10 observational studies selected at
random from a group of 30 identified during a systematic
review of HIV prevalence in MSM and associated risk fac-
tors. The reviewers were given guidance with regard to the
interpretation of the items included in the checklist before
reviewing the papers. Inter-rater reliability was shown to
be good (Pearson coefficient = 0.86).
In order to evaluate the practicality of the tool, the time
used to assess each paper was recorded. Both reviewers
reported that they took an average of 10.4 ± 4.6 minutes
to assess one paper with QATSO Score as compared to
23.0 ± 4.5 (p < 0.001) spent applying a validated lengthy
checklist (comprising of 27-items) reported elsewhere
[11].
Implementation
We searched articles published in English and Chinese
languages in the following electronic databases:
MEDLINE (1966 to December 2006), EMBASE (1980 to
December 2006), ProQuest Social Science Journal (1989
to December 2006), Anthropology (1984 to 1996), China
Journal Net (1994 to December 2006) and Wan Fang
Data (1998 to December 2006). To retrieve publications
reporting HIV prevalence and risk behaviours among
MSM in Mainland China, we performed a combined
search strategy that included the following terms as both
medical subject heading (MeSH) terms and text words:
"prevalence", "epidemiology", "HIV infections",
"Acquired Immunodeficiency Syndrome", "AIDS",
"MSM", "male having sex with male", "men having sex
with men", "men who have sex with men", "homosexual-
ity, male", "gay", "homosexual", "bisexual", "queer",
"male sex worker", "male sexual worker", sexual risk
behaviour", sexual behaviour", "risk taking", "risk fac-
tors", "protective factors", "China" and "Tibet". We man-
ually searched for review articles and abstracts from the
reference list of identified articles. Additional reports from
known experts in field through our contacts and profes-
sionals were included for review.
Data were independently abstracted onto a standardized
form by two independent reviewers. Data abstracted
included study design, time period of study, place of ori-
gin, study setting, HIV prevalence, information source for
exposure measurement, total number of persons in each
group, odds ratio or risk ratios, with and without adjust-
ment for potential. Conflicts in data abstraction were
resolved by consensus. Data reporting conforms to the
Meta-analysis of Observational Studies in Epidemiology
(MOOSE) study group guidelines [7]. QATSO is then
applied to assess the standard of each paper that fulfils the
inclusion criteria.
During this process, we found that QATSO may over-sim-
plify and generalise information one could extract from a
published manuscript, an issue inherent in all quality
assessment tools. For example, the relative importance of
individual items will be lost through a summation of
items represented by a total score. A careful balance has to
be struck so that the final scale is inclusive and allows
comparability between papers, yet is simple and practical
to use. Secondly, any attempts at summarising quality on,
for example, the inclusion or exclusion of a particular
item, will invariably lose the significance of that item's
magnitude. For example, a reported response rate per se
does not necessarily mean that the response rate is satis-
factory (item three in the scale); we therefore selected an
arbitrary 60% response rate as a cut-off for acceptable
quality. However, it is important to emphasise that the
objective of this tool is to appraise and guide study qual-
ity; actual analyses are conducted in the next phase of sys-
tematic review or meta-analysis which will be reported
elsewhere.
Conclusion
Few quality assessment tools for the systematic review of
observational studies are available and relevant for HIV
prevalence in MSM and associated risk behaviours. We
have developed a specific tool that researchers who wish
to conduct similar systematic reviews can adopt to ensure
that studies reach a level of quality that permit their inclu-
sion on meta-analyses.
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